Colgate Announces 1st Quarter 2021 Results
- Net sales increased 6.0%, Organic sales* increased 5.0%
- On a GAAP basis, EPS declined 4% to
$0.80 ; On a Base Business basis, EPS* grew 7% to$0.80 - GAAP Gross profit margin increased 50 basis points to 60.7%; Base Business Gross profit margin* increased 40 basis points to 60.7%
- Net cash provided by operations was
$598 million year to date - Colgate’s leadership in toothpaste continued with its global market share at 39.2% year to date
- Colgate’s leadership in manual toothbrushes continued with its global market share at 30.6% year to date
- The Company reiterated its financial guidance for full year 2021
First Quarter Total Company Results (GAAP) |
||||
($ in millions except per share amounts) |
2021 |
2020 |
Change |
|
|
|
|
+6.0 |
% |
EPS (diluted) |
|
|
-4 |
% |
|
|
|
|
|
|
|
|
|
|
First Quarter Total Company Results (Base Business - Non-GAAP)* |
||||
($ in millions except per share amounts) |
2021 |
2020 |
Change |
|
Organic Sales Growth |
+5.0 |
% |
||
Base Business EPS (diluted) |
|
|
+7 |
% |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” and “Table 6 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
“The strong results reflect the impact of our increased investments in premium innovation, digital transformation and advertising. We continue to strengthen our capabilities in these areas and, while there is more to do, we are pleased with the progress we are making.
“We continue to plan for increased advertising behind our brands and have an exciting pipeline of innovation planned for the balance of the year across all of our product categories.
“Looking ahead, we are seeing volatility in consumer demand and currencies as well as further increases in raw material prices and logistics costs, but remain confident that our investment choices and growth strategies will help us manage through these challenges and emerge even stronger.”
Full Year 2021 Guidance
Based on current spot rates:
- The Company expects net sales to be up 4% to 7% including a low-single-digit benefit from foreign exchange.
- The Company expects organic sales to be up within its long-term targeted range of 3% to 5%.
- On a GAAP basis, the Company expects gross margin expansion, increased advertising investment and low to mid-single-digit earnings-per-share growth.
- On a non-GAAP (Base Business) basis, the Company expects gross margin expansion, increased advertising investment and mid to high-single-digit earnings-per-share growth.
Divisional Performance
The following are comments about divisional performance for first quarter 2021 versus the year ago period. See attached "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 4 - Segment Information" for additional information on net sales and operating profit by division.
First Quarter Sales Growth By Division (% change 1Q 2021 vs. 1Q 2020) |
|
|
|
|||
|
Net Sales |
Organic Sales* |
As Reported Volume |
Organic Volume |
Pricing |
FX |
|
-0.5% |
-1.5% |
-6.5% |
-7.0% |
+5.5% |
+0.5% |
|
+2.0% |
+9.5% |
+1.0% |
+1.0% |
+8.5% |
-7.5% |
|
+6.0% |
-2.0% |
-3.5% |
-3.5% |
+1.5% |
+8.0% |
|
+16.5% |
+11.0% |
+10.5% |
+10.5% |
+0.5% |
+5.5% |
|
+8.5% |
+13.0% |
+5.0% |
+5.0% |
+8.0% |
-4.5% |
Hill's |
+9.5% |
+7.0% |
+3.0% |
+3.0% |
+4.0% |
+2.5% |
|
|
|
|
|
|
|
|
+6.0% |
+5.0% |
+0.5% |
+0.5% |
+4.5% |
+1.0% |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
The impact of the previously disclosed acquisition of the hello oral care business on as reported volume was 0% for |
First Quarter Operating Profit By Division ($ in millions) |
|
|||
|
1Q 2021 |
% Change vs 1Q 2020 |
% to Net Sales |
Change in basis points vs 1Q 2020 % to |
|
|
-22% |
21.9% |
-590 |
|
|
10% |
30.0% |
+210 |
|
|
17% |
25.1% |
+230 |
|
|
39% |
30.3% |
+490 |
|
|
-4% |
19.9% |
-230 |
Hill's |
|
6% |
27.4% |
-80 |
|
|
|
|
|
|
|
5% |
23.1% |
-10 |
|
|
5% |
23.1% |
-30 |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
- An organic sales decline in
the United States was partially offset by organic sales growth inCanada . - In
the United States , Colgate's share of the toothpaste market is 34.1% year to date and its share of the manual toothbrush market is 40.1% year to date. - The decrease in Operating profit as a percentage of Net sales was primarily due to higher raw and packaging material costs, higher overhead expenses, primarily driven by higher logistics costs, and increased advertising investment, partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives.
- Organic sales growth was led by
Brazil ,Mexico ,Argentina andColombia . - The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, cost savings from the Company’s funding-the-growth initiatives and decreased advertising investment, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs, and higher overhead expenses.
- Organic sales declines in
Germany and theUnited Kingdom were partially offset by organic sales growth in the Nordic region andSwitzerland . - The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives, lower overhead expenses, higher pricing and favorable mix, partially offset by higher raw and packaging material costs.
- Organic sales growth was led by the
Greater China region,India ,the Philippines andThailand . - The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company's funding-the-growth initiatives, lower overhead expenses, lower manufacturing costs, higher pricing and lower raw and packaging material costs.
- Organic sales growth was led by
Turkey ,Nigeria ,South Africa andRussia . - The decrease in Operating profit as a percentage of Net sales was primarily due to higher raw and packaging material costs, which included foreign exchange transaction costs, and higher overhead expenses, primarily driven by higher logistics costs, partially offset by higher pricing, cost savings from the Company’s funding-the-growth initiatives and decreased advertising investment.
Hill's Pet Nutrition (18% of Company Sales)
- Organic sales growth was led by
the United States ,Europe andCanada . - The decrease in Operating profit as a percentage of Net sales was primarily due to increased advertising investment and higher raw and packaging material costs, partially offset by lower overhead expenses, higher pricing and cost savings from the Company’s funding-the-growth initiatives.
Webcast Information
At
About
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking statements (as that term is defined in the
Non-GAAP Financial Measures
The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and/or the related webcast, which may not be the same as or comparable to similar measures presented by other companies:
- Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, acquisition-related costs and a benefit related to a reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure implemented within one of the Company's divisions.
- Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
- Free cash flow before dividends: Net cash provided by operations less Capital expenditures.
This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three months ended
Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the three months ended
(See attached tables for first quarter results.)
|
|
|
|
Table 1 |
|||||
|
|||||||||
|
|||||||||
Condensed Consolidated Statements of Income |
|||||||||
|
|||||||||
For the Three Months Ended |
|||||||||
|
|||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
|||||||||
|
|||||||||
|
|
2021 |
|
2020 |
|||||
|
|
|
|
|
|||||
Net sales |
|
$ |
4,344 |
|
|
$ |
4,097 |
|
|
|
|
|
|
|
|||||
Cost of sales |
|
1,707 |
|
|
1,632 |
|
|||
|
|
|
|
|
|||||
Gross profit |
|
2,637 |
|
|
2,465 |
|
|||
|
|
|
|
|
|||||
Gross profit margin |
|
60.7 |
% |
|
60.2 |
% |
|||
|
|
|
|
|
|||||
Selling, general and administrative expenses |
|
1,605 |
|
|
1,473 |
|
|||
|
|
|
|
|
|||||
Other (income) expense, net |
|
28 |
|
|
40 |
|
|||
|
|
|
|
|
|||||
Operating profit |
|
1,004 |
|
|
952 |
|
|||
|
|
|
|
|
|||||
Operating profit margin |
|
23.1 |
% |
|
23.2 |
% |
|||
|
|
|
|
|
|||||
Non-service related postretirement costs |
|
18 |
|
|
21 |
|
|||
|
|
|
|
|
|||||
Interest (income) expense, net |
|
29 |
|
|
36 |
|
|||
|
|
|
|
|
|||||
Income before income taxes |
|
957 |
|
|
895 |
|
|||
|
|
|
|
|
|||||
Provision for income taxes |
|
229 |
|
|
147 |
|
|||
|
|
|
|
|
|||||
Effective tax rate |
|
23.9 |
% |
|
16.4 |
% |
|||
|
|
|
|
|
|||||
Net income including noncontrolling interests |
|
728 |
|
|
748 |
|
|||
|
|
|
|
|
|||||
Less: Net income attributable to noncontrolling interests |
|
47 |
|
|
33 |
|
|||
|
|
|
|
|
|||||
Net income attributable to |
|
$ |
681 |
|
|
$ |
715 |
|
|
|
|
|
|
|
|||||
Earnings per common share |
|
|
|
|
|||||
Basic |
|
$ |
0.80 |
|
|
$ |
0.83 |
|
|
Diluted |
|
$ |
0.80 |
|
|
$ |
0.83 |
|
|
|
|
|
|
|
|||||
Supplemental Income Statement Information |
|
|
|
|
|||||
Average common shares outstanding |
|
|
|
|
|||||
Basic |
|
848.6 |
|
|
856.9 |
|
|||
Diluted |
|
851.4 |
|
|
858.4 |
|
|||
|
|
|
|
|
|||||
Advertising |
|
$ |
535 |
|
|
$ |
484 |
|
|
|
|
|
|
Table 2 |
|||||||
|
||||||||||||
|
||||||||||||
Condensed Consolidated Balance Sheets |
||||||||||||
|
||||||||||||
As of |
||||||||||||
|
||||||||||||
(Dollars in Millions) (Unaudited) |
||||||||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
2021 |
|
2020 |
|
2020 |
||||||
Cash and cash equivalents |
|
$ |
995 |
|
|
$ |
888 |
|
|
$ |
854 |
|
Receivables, net |
|
1,402 |
|
|
1,264 |
|
|
1,551 |
|
|||
Inventories |
|
1,676 |
|
|
1,673 |
|
|
1,301 |
|
|||
Other current assets |
|
490 |
|
|
513 |
|
|
542 |
|
|||
Property, plant and equipment, net |
|
3,609 |
|
|
3,716 |
|
|
3,487 |
|
|||
|
|
3,701 |
|
|
3,824 |
|
|
3,559 |
|
|||
Other intangible assets, net |
|
2,787 |
|
|
2,894 |
|
|
2,822 |
|
|||
Other assets |
|
1,141 |
|
|
1,148 |
|
|
954 |
|
|||
Total assets |
|
$ |
15,801 |
|
|
$ |
15,920 |
|
|
$ |
15,070 |
|
|
|
|
|
|
|
|
||||||
Total debt |
|
$ |
7,833 |
|
|
$ |
7,601 |
|
|
$ |
7,846 |
|
Other current liabilities |
|
4,276 |
|
|
4,137 |
|
|
3,933 |
|
|||
Other non-current liabilities |
|
3,029 |
|
|
3,081 |
|
|
2,950 |
|
|||
Total liabilities |
|
15,138 |
|
|
14,819 |
|
|
14,729 |
|
|||
|
|
262 |
|
|
743 |
|
|
(113 |
) |
|||
Noncontrolling interests |
|
401 |
|
|
358 |
|
|
454 |
|
|||
Total liabilities and equity |
|
$ |
15,801 |
|
|
$ |
15,920 |
|
|
$ |
15,070 |
|
|
|
|
|
|
|
|
||||||
Supplemental Balance Sheet Information |
|
|
|
|
|
|
||||||
Debt less cash, cash equivalents and marketable securities(1) |
|
$ |
6,776 |
|
|
$ |
6,676 |
|
|
$ |
6,949 |
|
Working capital % of sales |
|
(4.4 |
)% |
|
(4.4 |
)% |
|
(3.5 |
)% |
Note: |
(1) Marketable securities of |
|
|
|
|
Table 3 |
||||
|
||||||||
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
|
||||||||
For the Three Months Ended |
||||||||
|
||||||||
(Dollars in Millions) (Unaudited) |
||||||||
|
|
|
|
|
||||
|
|
2021 |
|
2020 |
||||
Operating Activities |
|
|
|
|
||||
Net income including noncontrolling interests |
|
$ |
728 |
|
|
$ |
748 |
|
Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations: |
|
|
||||||
Depreciation and amortization |
|
137 |
|
|
133 |
|
||
Restructuring and termination benefits, net of cash |
|
(13 |
) |
|
(30 |
) |
||
Stock-based compensation expense |
|
38 |
|
|
16 |
|
||
Deferred income taxes |
|
6 |
|
|
(99 |
) |
||
Cash effects of changes in: |
|
|
|
|
||||
Receivables |
|
(170 |
) |
|
(211 |
) |
||
Inventories |
|
(40 |
) |
|
29 |
|
||
Accounts payable and other accruals |
|
(75 |
) |
|
220 |
|
||
Other non-current assets and liabilities |
|
(13 |
) |
|
(38 |
) |
||
Net cash provided by (used in) operations |
|
598 |
|
|
768 |
|
||
|
|
|
|
|
||||
Investing Activities |
|
|
|
|
||||
Capital expenditures |
|
(107 |
) |
|
(82 |
) |
||
Purchases of marketable securities and investments |
|
(29 |
) |
|
(42 |
) |
||
Proceeds from sale of marketable securities and investments |
|
— |
|
|
16 |
|
||
Payment for acquisitions, net of cash acquired |
|
— |
|
|
(351 |
) |
||
Other investing activities |
|
(6 |
) |
|
— |
|
||
Net cash provided by (used in) investing activities |
|
(142 |
) |
|
(459 |
) |
||
|
|
|
|
|
||||
Financing Activities |
|
|
|
|
||||
Short-term borrowing (repayment) less than 90 days, net |
|
365 |
|
|
17 |
|
||
Proceeds from issuance of debt |
|
25 |
|
|
— |
|
||
Dividends paid |
(376 |
) |
(373 |
) |
||||
Purchases of treasury shares |
|
(372 |
) |
|
(220 |
) |
||
Proceeds from exercise of stock options |
|
30 |
|
|
297 |
|
||
Other financing activities |
|
(6 |
) |
|
(29 |
) |
||
Net cash provided by (used in) financing activities |
|
(334 |
) |
|
(308 |
) |
||
|
|
|
|
|
||||
Effect of exchange rate changes on Cash and cash equivalents |
|
(15 |
) |
|
(30 |
) |
||
Net increase (decrease) in Cash and cash equivalents |
|
107 |
|
|
(29 |
) |
||
Cash and cash equivalents at beginning of the period |
|
888 |
|
|
883 |
|
||
Cash and cash equivalents at end of the period |
|
$ |
995 |
|
|
$ |
854 |
|
|
|
|
|
|
||||
Supplemental Cash Flow Information |
|
|
|
|
||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) |
|
|
|
|
||||
Net cash provided by operations |
|
$ |
598 |
|
|
$ |
768 |
|
Less: Capital expenditures |
|
(107 |
) |
|
(82 |
) |
||
Free cash flow before dividends |
|
$ |
491 |
|
|
$ |
686 |
|
|
|
|
|
|
||||
|
|
|
|
|
||||
Income taxes paid |
|
$ |
227 |
|
|
$ |
128 |
|
|
|
|
Table 4 |
|||||
|
||||||||
|
||||||||
Segment Information |
||||||||
|
||||||||
For the Three Months Ended |
||||||||
|
||||||||
(Dollars in Millions) (Unaudited) |
||||||||
|
|
|
||||||
|
|
Three Months Ended |
||||||
|
|
2021 |
|
2020 |
||||
|
|
|
|
|
||||
Oral, Personal and Home Care |
|
|
|
|
||||
|
|
|
|
|
||||
|
|
$ |
923 |
|
|
$ |
929 |
|
|
|
907 |
|
|
889 |
|
||
|
|
717 |
|
|
675 |
|
||
|
|
739 |
|
|
633 |
|
||
|
|
272 |
|
|
252 |
|
||
|
|
|
|
|
||||
Total Oral, Personal and Home Care |
|
3,558 |
|
|
3,378 |
|
||
|
|
|
|
|
||||
Pet Nutrition |
|
786 |
|
|
719 |
|
||
|
|
|
|
|
||||
Total |
|
$ |
4,344 |
|
|
$ |
4,097 |
|
|
|
|
|
|
||||
|
|
|
|
|
||||
|
|
Three Months Ended |
||||||
|
|
2021 |
|
2020 |
||||
Operating Profit |
|
|
|
|
||||
Oral, Personal and Home Care |
|
|
|
|
||||
|
|
|
|
|
||||
|
|
$ |
202 |
|
|
$ |
258 |
|
|
|
272 |
|
|
248 |
|
||
|
|
180 |
|
|
154 |
|
||
|
|
224 |
|
|
161 |
|
||
|
|
54 |
|
|
56 |
|
||
|
|
|
|
|
||||
Total Oral, Personal and Home Care |
|
932 |
|
|
877 |
|
||
|
|
|
|
|
||||
Pet Nutrition |
|
215 |
|
|
203 |
|
||
Corporate(1) |
|
(143 |
) |
|
(128 |
) |
||
|
|
|
|
|
||||
Total Operating Profit |
|
$ |
1,004 |
|
|
$ |
952 |
|
Note: |
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. |
Corporate Operating profit (loss) for the three months ended |
Table 5 |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
Geographic Sales Analysis Percentage Changes |
||||||||||||||||||
|
||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||
|
||||||||||||||||||
(Unaudited) |
||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
Pricing |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
Coupons |
|
|
||||||
|
|
Sales |
|
|
|
|
|
|
|
Consumer & |
|
|
||||||
|
|
Change |
|
Organic |
|
As Reported |
|
Organic |
|
Trade |
|
Foreign |
||||||
Region |
|
As Reported |
|
Sales Change |
|
Volume |
|
Volume |
|
Incentives |
|
Exchange |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
6.0 |
% |
|
5.0 |
% |
|
0.5 |
% |
|
0.5 |
% |
|
4.5 |
% |
|
1.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
(0.5) |
% |
|
(1.5) |
% |
|
(6.5) |
% |
|
(7.0) |
% |
|
5.5 |
% |
|
0.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2.0 |
% |
|
9.5 |
% |
|
1.0 |
% |
|
1.0 |
% |
|
8.5 |
% |
|
(7.5) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
6.0 |
% |
|
(2.0) |
% |
|
(3.5) |
% |
|
(3.5) |
% |
|
1.5 |
% |
|
8.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
16.5 |
% |
|
11.0 |
% |
|
10.5 |
% |
|
10.5 |
% |
|
0.5 |
% |
|
5.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
8.5 |
% |
|
13.0 |
% |
|
5.0 |
% |
|
5.0 |
% |
|
8.0 |
% |
|
(4.5) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total CP Products(1) |
|
5.5 |
% |
|
4.5 |
% |
|
— |
% |
|
— |
% |
|
4.5 |
% |
|
1.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Hill’s |
|
9.5 |
% |
|
7.0 |
% |
|
3.0 |
% |
|
3.0 |
% |
|
4.0 |
% |
|
2.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Emerging Markets(2) |
|
8.5 |
% |
|
11.5 |
% |
|
5.5 |
% |
|
5.5 |
% |
|
6.0 |
% |
|
(3.0) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Developed Markets(1) |
|
4.0 |
% |
|
— |
% |
|
(3.5) |
% |
|
(3.5) |
% |
|
3.5 |
% |
|
4.0 |
% |
Notes: |
(1) The impact of the previously disclosed acquisition of the hello oral care business on as reported volume was 0% for |
(2) Emerging Markets include |
Table 6 |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Non-GAAP Reconciliations |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross Profit |
|
|
|
|
|
|
|
2021 |
|
2020 |
|
|
||||||||||||||
Gross profit, GAAP |
|
|
|
|
|
|
|
$ |
2,637 |
|
|
$ |
2,465 |
|
|
|
||||||||||
Acquisition-related costs |
|
|
|
|
|
|
|
— |
|
|
4 |
|
|
|
||||||||||||
Gross profit, non-GAAP |
|
|
|
|
|
|
|
$ |
2,637 |
|
|
$ |
2,469 |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross Profit Margin |
|
|
|
|
|
|
|
2021 |
|
2020 |
|
Change |
||||||||||||||
Gross profit margin, GAAP |
|
|
|
|
|
|
|
60.7 |
% |
|
60.2 |
% |
|
50 |
|
|||||||||||
Acquisition-related costs |
|
|
|
|
|
|
|
— |
% |
|
0.1 |
% |
|
|
||||||||||||
Gross profit margin, non-GAAP |
|
|
|
|
|
|
|
60.7 |
% |
|
60.3 |
% |
|
40 |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Other (Income) Expense, Net |
|
|
|
|
2021 |
|
2020 |
|
|
|||||||||||||||||
Other (income) expense, net, GAAP |
|
|
|
|
$ |
28 |
|
|
$ |
40 |
|
|
|
|||||||||||||
Acquisition-related costs |
|
|
|
|
— |
|
|
(2 |
) |
|
|
|||||||||||||||
Other (income) expense, net, non-GAAP |
|
|
|
|
$ |
28 |
|
|
$ |
38 |
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating Profit |
|
|
|
|
2021 |
|
2020 |
|
% Change |
|||||||||||||||||
Operating profit, GAAP |
|
|
|
|
$ |
1,004 |
|
|
$ |
952 |
|
|
5 |
% |
||||||||||||
Acquisition-related costs |
|
|
|
|
— |
|
|
6 |
|
|
|
|||||||||||||||
Operating profit, non-GAAP |
|
|
|
|
$ |
1,004 |
|
|
$ |
958 |
|
|
5 |
% |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating Profit Margin |
|
|
|
|
2021 |
|
2020 |
|
Change |
|||||||||||||||||
Operating profit margin, GAAP |
|
|
|
|
23.1 |
% |
|
23.2 |
% |
|
(10 |
) |
||||||||||||||
Acquisition-related costs |
|
|
|
|
— |
% |
|
0.2 |
% |
|
|
|||||||||||||||
Operating profit margin, non-GAAP |
|
|
|
|
23.1 |
% |
|
23.4 |
% |
|
(30 |
) |
||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
2020 |
|||||||||||||||||||||||||
|
Income Before Income Taxes |
|
Provision For Income Taxes(1) |
|
Net Income Including Noncontrolling Interests |
|
Net Income Attributable To Company |
|
Effective Income Tax Rate(2) |
|
Diluted Earnings Per Share |
|||||||||||||||
As Reported GAAP |
$ |
895 |
|
|
$ |
147 |
|
|
$ |
748 |
|
|
|
$ |
715 |
|
|
16.4 |
% |
|
$ |
0.83 |
|
|||
Subsidiary and operating structure initiatives |
— |
|
|
71 |
|
|
(71 |
) |
|
|
(71 |
) |
|
7.9 |
% |
|
(0.08 |
) |
||||||||
Acquisition-related costs |
6 |
|
|
2 |
|
|
4 |
|
|
|
4 |
|
|
0.1 |
% |
|
— |
|
||||||||
Non-GAAP |
$ |
901 |
|
|
$ |
220 |
|
|
$ |
681 |
|
|
|
$ |
648 |
|
|
24.4 |
% |
|
$ |
0.75 |
|
|||
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
Source: